|Day Low/High||66.11 / 67.49|
|52 Wk Low/High||26.80 / 73.54|
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANIP, AXU, BLDP, DVD, EGN, GPIC, IEC, IRS, OVBC, PIH, SAIA, VCO, WILC Downgrades: EFOI, LILAK, PCH, PEGA, PNM, PW, SUI, TOT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
In recent trading, shares of ANI Pharmaceuticals, Inc. have crossed above the average analyst 12-month target price of $66.00, changing hands for $66.39/share.
Trade-Ideas LLC identified ANI Pharmaceuticals (ANIP) as a strong on high relative volume candidate
Investors eyeing a purchase of ANI Pharmaceuticals, Inc. stock, but cautious about paying the going market price of $59.32/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Here's a technical look at how to trade five stocks poised for breakouts.
Investors considering a purchase of ANI Pharmaceuticals, Inc. stock, but tentative about paying the going market price of $47.54/share, might benefit from considering selling puts among the alternative strategies at their disposal.